Galderma Group AG Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	231	-57	-98.5	-154.3
Depreciation & Amortization	249	236	251.1	239
Other Amortization	44	40	26.6	14.1
Loss (Gain) From Sale of Assets	-	-	0.7	-
Asset Writedown & Restructuring Costs	-	1	15.2	18.7
Stock-Based Compensation	68	-	-	-
Other Operating Activities	44	-20	-5.3	-17.7
Change in Accounts Receivable	-208	47	-66.9	-36.9
Change in Inventory	-12	31	-127.4	-52.8
Change in Accounts Payable	64	-66	146.2	155.2
Change in Other Net Operating Assets	8	-47	-30.4	-39.9
Operating Cash Flow	488	165	111.3	195.7
Operating Cash Flow Growth	195.76%	48.25%	-43.13%	-
Capital Expenditures	-128	-121	-101.6	-49.9
Sale of Property, Plant & Equipment	-	3	-	-
Cash Acquisitions	-50	-25	-	-386.8
Sale (Purchase) of Intangibles	-147	-31	-57.9	-78.1
Investment in Securities	-	-	-	-8
Other Investing Activities	-1	-	93	-
Investing Cash Flow	-326	-174	-66.5	-522.8
Long-Term Debt Issued	3,601	856	400	396
Long-Term Debt Repaid	-5,777	-1,725	-472.1	-78.8
Net Debt Issued (Repaid)	-2,176	-869	-72.1	317.2
Issuance of Common Stock	2,166	1,011	-	-
Repurchase of Common Stock	-15	-	-	-
Other Financing Activities	-33	-	-7.3	-10.7
Financing Cash Flow	-58	142	-79.4	306.5
Foreign Exchange Rate Adjustments	-14	-	-24.9	-16.5
Miscellaneous Cash Flow Adjustments	-1	1	-	-
Net Cash Flow	89	134	-59.5	-37.1
Free Cash Flow	360	44	9.7	145.8
Free Cash Flow Growth	718.18%	353.61%	-93.35%	-
Free Cash Flow Margin	8.11%	1.07%	0.25%	4.23%
Free Cash Flow Per Share	1.51	0.18	0.00	0.03
Cash Interest Paid	286	532	339.1	305.6
Cash Income Tax Paid	90	87	73.6	48.9
Levered Free Cash Flow	131.38	136.43	196.36	-
Unlevered Free Cash Flow	351.38	487.05	445.36	-
Change in Net Working Capital	154	15.7	-76.6	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.